Citing concerns with the increasing prevalence of cannabis in the country, the Prime Minister plans to curb ongoing legalization.
In a recent television interview, Thailand’s newly elected Prime Minister, Srettha Thavisin, stated that sales and consumption of cannabis for recreational purposes is too extensive and declared an effort to halt ongoing legalization in the country (1). Within the next six months, the government will reportedly limit use to medical purposes only, though details of the exact plans remain unclear (2,3).
In 2018, Thailand became the first country in Asia to allow cannabis for medical use, and in 2022 the country legalized cannabis for recreational use and removed it from the list of narcotics (2). Currently, anyone over the age of 20 who is not pregnant or breastfeeding is legally allowed to use cannabis or consume its extracts in food in private residences or in licensed restaurants (3). Home cultivation is also permitted, but only after informing the Thai government first (2). Despite these permissions, Thailand does not have regulations controlling the growing and selling of cannabis (2).
“The law will need to be rewritten,” Srettha stated (3). “It needs to be rectified. We can have that regulated for medical use only.” He also explained that an agreement had been formed among the 11 political parties to sanctify this push as government policy, citing widespread drug activity (2).
Since decriminalization, the country has nearly 6,000 cannabis stores, and according to a study published by "Bangkok Times" in 2022 from the University of the Thai Chamber of Commerce, the country’s cannabis market is expected to generate $1.68 billion in 2025 (2). The country has also seen the rise of cannabis-themed massages, cruises, and farm tours (4).
For a look into modern and traditional uses of psychedelics in Thailand, watch our onsite interview with Dr. Aimon Kopera at the Cannabis Science Conference Fall 2023.
References
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.